Who
Jack Anders
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Revolution Medicines.
In numbers
- Trades disclosed
- 97
- Buys
- 0
- Sells
- 33
- Bought
- $0
- Sold
- $16.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Feb 2020
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $12K61 at $195.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $796K3,992 at $199.30 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $12K61 at $195.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $796K3,992 at $199.30 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $371K20,000 at $18.56 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $762K4,553 at $167.35 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.6M9,496 at $168.20 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $956K5,651 at $169.24 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $51K300 at $170.32 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Code M | $371K20,000 at $18.56 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $762K4,553 at $167.35 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.6M9,496 at $168.20 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $956K5,651 at $169.24 | filing |
| 24 Jun 2026filed 26 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $51K300 at $170.32 | filing |
| 16 Jun 2026filed 18 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $425K2,722 at $156.12 | filing |
| 16 Jun 2026filed 18 Jun 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $425K2,722 at $156.12 | filing |
| 17 Mar 2026filed 19 Mar 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $274K2,753 at $99.48 | filing |
| 17 Mar 2026filed 19 Mar 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $274K2,753 at $99.48 | filing |
News
Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026RVMD · manilatimes.net · 23 Oct 2026Contrasting Revolution Medicines (NASDAQ:RVMD) and Agios Pharmaceuticals (NASDAQ:AGIO)RVMD · themarketsdaily.com · 22 Oct 20263,946 Shares of Revolution Medicines, Inc. $RVMD Acquired by Vontobel Holding Ltd.RVMD · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Jack Anders; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.